Duncan McHale - 27 May 2022 Form 4 Insider Report for Evelo Biosciences, Inc.

Signature
/s/ Daniel S. Char, Attorney-in-Fact for Duncan McHale
Issuer symbol
EVLO on OTC
Transactions as of
27 May 2022
Net transactions value
+$49,999
Form type
4
Filing time
31 May 2022, 16:15:27 UTC
Previous filing
21 Jan 2022
Next filing
09 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVLO Common Stock Purchase $49,999 +34,246 $1.46* 34,246 27 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.